Course Directors

meet our Course Directors

Dr. Dupoiron

Dr Denis Dupoiron, MD 

N° RPPS: 10002537776

 

Postal Address

Institut de cancérologie de l’Ouest Paul Papin

15 Rue Boquel

49055 ANGERS CEDEX

FRANCE 

Email : denis.dupoiron@ico.unicancer.fr

 

Anesthesiology and Pain medicine

Head of Pain department of ICO - Institut de Cancérologie de L’Ouest - Angers 

 

  • Development of intrathecal analgesia for more than 10 years as a solution especially for refractory pain patients in oncology.  
  • Ziconotide use in oncology: stability, dosages, adverse effects 
  • Capsaicin use in oncology 

 

Bibliography 

  1. Antoun, S., et al., Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used? World J Surg, 2009. 33(8): p. 1633-40.
  2. Giquello, J.A., et al., Septic uveitis revealing internal jugular vein thrombophlebitis. Lancet Infect Dis, 2011. 11(4): p. 332.
  3. Dupoiron, D., et al., Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol. Pain Physician, 2012. 15(5): p. 395-403. 
  4. Brenet, O., et al., Hypersensitivity reactions to Patent Blue V in breast cancer surgery: a prospective multicentre study.Acta Anaesthesiol Scand, 2013. 57(1): p. 106-11. 
  5. Dupoiron, D., et al., In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.Neuromodulation, 2014. 17(5): p. 472-82; discussion 482. 
  6. Bazin, C., A.L. Poirier, and D. Dupoiron, Influence of pH and temperature on ziconotide stability in intrathecal analgesic admixtures in implantable pumps and syringes. Int J Pharm, 2015. 487(1-2): p. 285-91. 
  7. Beydon, L., et al., Sedative premedication before surgery--A multicentre randomized study versus placebo. Anaesth Crit Care Pain Med, 2015. 34(3): p. 165-71. 
  8. Dupoiron, D., et al., Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice. Pain Physician, 2015. 18(4): p. 349-57. 
  9. Marcy, P.Y., et al., [Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices]. Bull Cancer, 2015. 102(4): p. 301-15. 
  10. Staquet, H., et al., Intracerebroventricular Pain Treatment with Analgesic Mixtures including Ziconotide for Intractable Pain. Pain Physician, 2016. 19(6): p. E905-15. 
  11. Dupoiron, D., et al., A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain, 2017. 21(9): p. 1528-1537. 
  12. Dupoiron, D., et al., Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study. Eur J Pain, 2017. 21(9): p. 1485-1494. 
  13. Lorimier, G., et al., Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. Eur J Surg Oncol, 2017. 43(1): p. 150-158. 
  14. Marcy, P.Y., et al., Patient satisfaction and acceptance of their totally implanted central venous catheter: a French prospective multicenter study. J Vasc Access, 2017. 18(5): p. 390-395. 
  15. Robert, J., et al., Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia. Int J Pharm Compd, 2017. 21(4): p. 347-351. 
  16. Carvajal, G., et al., Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center. Anesth Analg, 2018. 126(6): p. 2038-2046. 
  17. Dupoiron, D. and G. Carvajal, High-Resolution Three-Dimensional Computed Tomography Reconstruction as First-Line Imaging Modality to Detect Intrathecal Catheter Malfunction. Neuromodulation, 2018. 21(7): p. 717-720. 
  18. Lorimier, G., et al., Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study.Eur J Surg Oncol, 2018. 44(11): p. 1824-1831. 
  19. Sorrieul, J., et al., Validated chromatographic method for the simultaneous determination of eight drugs (morphine, ropivacaine, bupivacaine, baclofen, clonidine, sufentanil, fentanyl and ziconotide) for intrathecal analgesia. Ann Pharm Fr, 2018. 76(3): p. 201-209. 
  20. Sorrieul, J., et al., Stability of sufentanil and baclofen mixtures for intrathecal analgesia at different concentrations in polypropylene syringes. Ann Pharm Fr, 2018. 76(6): p. 444-452. 
  21. Dupoiron, D., Intrathecal therapy for pain in cancer patients. Curr Opin Support Palliat Care, 2019. 13(2): p. 75-80. 
  22. Dupoiron, D., et al., Optimizing Initial Intrathecal Drug Ratio for Refractory Cancer-Related Pain for Early Pain Relief. A Retrospective Monocentric Study. Pain Med, 2019. 
  23. Reynaert, M.L., et al., Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls. Toxins (Basel), 2019. 11(9).  

 


Dupoiron
For additional information, please contact us
  • Den Hert 3
  • 9250 Waasmunster, Belgium
© ECMT Training |